[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"South Tyneside and Sunderland NHS Foundation Trust\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":68},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,41],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":4,"maxAge":4,"enrollmentInfo":16,"targetDuration":4,"studyType":19,"phases":20,"briefSummary":22,"conditions":23,"keywords":28,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":36,"leadSponsor":38,"locationsCount":4},"100579263","virtual-reality-and-its-use-in-reducing-perioperative-stress-in-cataract-surgery-100579263",false,"NCT06822023","Virtual Reality and Its Use in Reducing Perioperative Stress in Cataract Surgery","Inclusion Criteria:\n\n1. Patients listed for cataract surgery under local anaesthetic (topical or regional) with sedation planned.\n2. First eye cataract procedures will only be included.\n3. Capacity to give informed consent, cognitive and linguistic ability sufficient to understand and fill out questionnaire\n\nExclusion Criteria:\n\n1. Epilepsy\n2. severe vertigo\n3. poor visual acuity (below 6\u002F60 best corrected in the best seeing eye)\n4. significant hearing impairment\n5. recent facial injury\u002Fburn.","ALL",{"count":17,"type":18},75,"ESTIMATED","INTERVENTIONAL",[21],"NA","This project is to evaluate the benefits of utilising virtual reality (VR) headsets with the aim of reducing peri-operative anxiety in cataract surgery and hence reducing the need for sedation in patients with significant stress levels noted during preassessment. This is a novel study, and with the increased use of VR technology throughout medicine, we may be able to offer our patients alternative management modalities to reduce stress and reduce need for medications with their subsequent potential side effects. It may also improve the quality of care provided and patients' experience with the cataract extraction procedure and might reduce the social care burden associated with standard sedation procedures. All patients will need to fill a quick preoperative anxiety and information scale questionnaire to assess their level of anxiety utilising The Amsterdam Preoperative Anxiety and Information Score.\n\nPatients will be randomised into 2 groups:\n\n1. Conventional group: patients will be prepared as per the standard routine clinical and further explanation of the procedure will be given. Before proceeding to the anaesthetic room, the patients will complete the anxiety score questionnaire again and given the option to proceed with sedation or opt out.\n2. Interventional Group: patients will be prepared as per the standard routine clinical care; they will then be wearing the VR mask for 10 minutes. Before proceeding to the anaesthetic room, patients will complete the anxiety score questionnaire again and given the option to proceed with sedation or opt out.\n\nPost operation, a record will be taken of the surgeon's decision on whether they want the second eye cataract surgery to be done under sedation (this is already standard practice at our centre). Finally, the patient will be asked to fill in one final grading score on whether they are happy with their decision to take\u002Fnot take sedation.",[24,25,26,27],"Virtual Reality","Eye Disease","Cataract Surgery Anesthesia","Cataract Surgery",[29],"cataract surgery, sedation, anxiety, virtual reality","NOT_YET_RECRUITING","2025-02-06",{"date":33,"type":34},"2025-02-12","ACTUAL",{"date":33,"type":18},{"date":37,"type":18},"2025-12-01",{"name":39,"class":40},"South Tyneside and Sunderland NHS Foundation Trust","OTHER",{"id":42,"slug":43,"hasResults":11,"nctId":44,"briefTitle":45,"officialTitle":45,"acronym":4,"eligibilityCriteria":46,"healthyVolunteers":11,"sex":15,"minAge":47,"maxAge":4,"enrollmentInfo":48,"targetDuration":4,"studyType":50,"phases":4,"briefSummary":51,"conditions":52,"keywords":4,"overallStatus":58,"whyStopped":4,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":67},"100376765","colo-cohort-colorectal-cancer-cohort-study-100376765","NCT04185779","COLO-COHORT (Colorectal Cancer Cohort) Study","Inclusion Criteria:\n\nGroup A\n\n* Aged ≥30 years\\* and able to give informed consent\n* Patients attending colonoscopy\n\n  * Through Bowel Cancer Screening Programme (FIT positive, Bowelscope conversion, surveillance)\n  * Through standard NHS care (most commonly due to iron deficiency anaemia, altered bowel habit, weight loss, rectal bleeding, planned polypectomy\\*\\*, those referred on basis of family history, abnormal cross-sectional imaging, polyp surveillance or post CRC surveillance)\n\n    * The age of 30 was chosen to ensure that this is a population likely to be enriched for colorectal neoplasia with neoplasia below this age uncommon \\*\\*In those attending for planned polypectomy, the results from the initial colonoscopy and the endoscopy where the polypectomy is undertaken will be summated for purposes of calculating the neoplasia profile\n\n(COLO-SPEED) Group B\n\n* Any patient attending for colonoscopy and able to give informed consent\n* ≥ 18 years old\n* Patient from the North of England\n\nExclusion Criteria:\n\nGroup A\n\n* Unable to give informed consent\n* Known polyposis syndrome\n* Previous total colectomy\n* Known colonic stricture which would limit complete colonoscopy\n* Attending for planned therapeutic procedure other than polypectomy, such as insertion of colonic stent\n* Attending for assessment of known inflammatory bowel disease (IBD) activity or for IBD surveillance\n* Patients currently recruited into an interventional CTIMP for CRC prevention\\*\n\nCOLO-SPEED (Group B) \\*\\*\n\n* Unable to give informed consent\n* Not in a centre supported by COLO-SPEED infrastructure (North of England)","18 Years",{"count":49,"type":18},15000,"OBSERVATIONAL","This is a cross-sectional study aimed at identifying factors which best predicts patients at high risk of colorectal cancer or colorectal adenomas and to develop a risk prediction model.",[53,54,55,56,57],"Colorectal Cancer","Colorectal Adenoma","Colorectal Neoplasm","Predictive Cancer Model","Model","RECRUITING","2020-10-19",{"date":61,"type":34},"2020-10-22",{"date":63,"type":34},"2019-12-13",{"date":65,"type":18},"2026-08-15",{"name":39,"class":40},3,""]